D2 What are the control arms for clinical trials in
recurrent ovarian cancer
•
In patients
where platinum is not an option
a control arm can
include a non-platinum drug as a single agent or in
combination.
5th OCCC of the GCIG: Recurrent Disease. Ann Oncol. 2016 Dec 19
